河北医学2024,Vol.30Issue(9) :1572-1577.DOI:10.3969/j.issn.1006-6233.2024.09.030

门冬胰岛素联合地特胰岛素治疗妊娠期糖尿病患者疗效及对血清NRG4 HGF SAA水平胰岛细胞功能的影响

Efficacy of Insulin Aspart Combined with Insulin Detemir in the Treatment of Patients with GDM and the Effect on Serum NRG4,HGF and SAA Levels and Islet Cell Function

邵晓洁 朱捷 孔玲玲 管文婕 杨洋 李健
河北医学2024,Vol.30Issue(9) :1572-1577.DOI:10.3969/j.issn.1006-6233.2024.09.030

门冬胰岛素联合地特胰岛素治疗妊娠期糖尿病患者疗效及对血清NRG4 HGF SAA水平胰岛细胞功能的影响

Efficacy of Insulin Aspart Combined with Insulin Detemir in the Treatment of Patients with GDM and the Effect on Serum NRG4,HGF and SAA Levels and Islet Cell Function

邵晓洁 1朱捷 1孔玲玲 2管文婕 1杨洋 1李健1
扫码查看

作者信息

  • 1. 中国人民解放军联勤保障部队第九〇一医院药剂科,安徽 合肥 230031
  • 2. 安徽省合肥市第三人民医院药剂科,安徽 合肥 230031
  • 折叠

摘要

目的:探讨门冬胰岛素联合地特胰岛素治疗妊娠期糖尿病(GDM)患者疗效及对血清神经调节蛋白4(NRG4)、肝细胞生长因子(HGF)、淀粉样蛋白 A(SAA)水平、胰岛细胞功能的影响.方法:选取2020 年6 月至2023 年6 月我院收治的113 例GDM患者,采用简单随机法分为对照组(n=56)和观察组(n=57),对照组给予门冬胰岛素联合精蛋白生物合成人胰岛素治疗,观察组给予门冬胰岛素联合地特胰岛素治疗,比较两组胰岛素使用情况和血糖达标时间、血糖[空腹血糖(FBG)、餐后 2h 血糖(2hPBG)、糖化血红蛋白(HbA1c)]及血清 NRG4、HGF、SAA 水平和胰岛细胞功能[胰岛素抵抗指数(HOMA-IR)、β细胞分泌指数(HOMA-β)、空腹胰岛素(FINS)]、妊娠结局.结果:观察组胰岛素用量和注射次数少于对照组,血糖达标时间短于对照组(P<0.05).观察组FBG、2hPBG、HbA1c 治疗前后差值均高于对照组(P<0.05).观察组血清NRG4、HGF、SAA水平治疗前后差值均高于对照组(P<0.05).观察组HOMA-β、HOMA-IR、FINS治疗前后差值均高于对照组(P<0.05).两组剖宫产、巨大儿、新生儿低血糖和胎儿呼吸窘迫发生率比较差异无统计学意义(P>0.05).结论:门冬胰岛素联合地特胰岛素治疗GDM疗效显著,可控制血糖,缩短血糖达标时间,改善血清 NRG4、HGF、SAA 水平和胰岛细胞功能.

Abstract

Objective:To investigate the efficacy of insulin aspart combined with insulin detemir in the treatment of GDM and the effect on serum neuregulin 4(NRG4),HGF,and amyloid A(SAA)levels and is-let cell function.Methods:From June 2020 to June 2023,113 patients with GDM were selected and randomly divided into the control group(n=56)and the observation group(n=57).The control group was treated with insulin aspart combined with premixed protamine recombinant human insulin while the observation group was treated with insulin aspart combined with insulin detemir.The two groups were compared on insulin use,time to blood glucose reaching the standard,blood glucose indicators(FBG,2hPBG,and HbA1c),serum NRG4,HGF and SAA levels,islet cell function indicators[HOMA-IR,Homeostasis Model Assessment of beta-cell(HOMA-β)and fasting insulin(FINS)]and pregnancy outcomes.Results:The dosage of insulin and injec-tion frequency in the observation group were lower than in the control group,and the time to blood glucose reaching the standard was shorter than that in the control group(P<0.05).The differences in FBG,2hPBG,HbA1c,serum NRG4,HGF and SAA levels,HOMA-β,HOMA-IR,and FINS before and after treatment in the observation group were greater than those in the control group(all P<0.05).There was no statistically significant difference in the incidence rates of cesarean section,fetal macrosomia,neonatal hypoglycemia,and fetal distress between the two groups(P>0.05).Conclusion:The combined treatment with insulin aspart and insulin detemir has a significant therapeutic effect on GDM,which can control blood glucose,shorten the time for blood glucose to reach the standard,and improve serum NRG4,HGF,and SAA levels as well as islet cell function.

关键词

妊娠期糖尿病/门冬胰岛素/地特胰岛素/神经调节蛋白4/肝细胞生长因子/淀粉样蛋白A/胰岛细胞功能

Key words

Gestational diabetes mellitus/Insulin aspart/Insulin detemir/Neuregulin 4/Hepatocyte growth factor/Amyloid A/Islet cell function

引用本文复制引用

基金项目

安徽省自然科学基金项目(200809QH40)

出版年

2024
河北医学
河北省医学会

河北医学

CSTPCD
影响因子:1.915
ISSN:1006-6233
参考文献量3
段落导航相关论文